Jine Zheng
Overview
Explore the profile of Jine Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li C, Xu J, Luo W, Liao D, Xie W, Wei Q, et al.
Leukemia
. 2023 Oct;
38(1):149-159.
PMID: 37848634
Multiple myeloma (MM) bears heterogeneous cells that poses a challenge for single-target immunotherapies. Here we constructed bispecific CS1-BCMA CAR-T cells aiming to augment BCMA targeting with CS1. Sixteen patients with...
2.
Lu C, Hu D, Zheng J, Cao S, Zhu J, Chen X, et al.
Biomed Res Int
. 2022 May;
2022:4010786.
PMID: 35528167
Tumor microenvironment (TME) has been revealed as an important determinant of diagnosis and treatment response in AML patients. The scores of immune and stromal cell scores of AML in the...
3.
Zhu T, Zhu Y, Xuan Y, Gao H, Cai X, Piersma S, et al.
Genomics Proteomics Bioinformatics
. 2020 Aug;
18(2):104-119.
PMID: 32795611
To address the increasing need for detecting and validating protein biomarkers in clinical specimens, mass spectrometry (MS)-based targeted proteomic techniques, including the selected reaction monitoring (SRM), parallel reaction monitoring (PRM),...
4.
Du W, He J, Zhou W, Shu S, Li J, Liu W, et al.
J Transl Med
. 2019 Jun;
17(1):191.
PMID: 31171000
Background: Elevated protein expressions of CD markers such as IL2RA/CD25, CXCR4/CD184, CD34 and CD56 are associated with adverse prognosis in acute myeloid leukemia (AML). However, the prognostic value of mRNA...
5.
Chen X, Zheng J, Liang K, He Y, Du W, Li J, et al.
Intern Med J
. 2017 Jun;
48(4):439-444.
PMID: 28636094
Background: Clonal Philadelphia (Ph)-negative cytogenetic abnormalities (CPCA) have been reported in chronic myeloid leukaemia (CML) patients treated with either interferon or tyrosine kinase inhibitor (TKI). However, the incidences and types...
6.
Du W, Li J, Liu W, He Y, Yao J, Liu Y, et al.
Tumour Biol
. 2015 Oct;
37(3):3817-21.
PMID: 26474588
Interleukin-3 (IL-3) receptor α chain (CD123) plays an essential role in regulating the proliferation of hematopoietic stem cells. In the hematopoietic malignancies, CD123 expression has been found in acute myeloid...
7.
He Y, Wang P, Liang K, Chen X, Du W, Li J, et al.
Medicine (Baltimore)
. 2015 Oct;
94(41):e1778.
PMID: 26469919
Acute promyelocytic leukemia (APL) is a specific malignant hematological disorder with a diagnostic hallmark of chromosome translocation t(15;17)(q22;q21). As a very rare secondary cytogenetic aberration in pediatric APL, ider(17q) (q10)t(15;17)...
8.
Du W, Hu Y, Lu C, Li J, Liu W, He Y, et al.
Mol Clin Oncol
. 2015 Jul;
3(4):833-838.
PMID: 26171191
Resistance to chemotherapy is a major challenge for leukemia treatment. It has been suggested that leukemia stem cells (LSCs), a small pool of self-renewing leukemic cells, play important roles in...
9.
Candelaria N, Addanki S, Zheng J, Nguyen-Vu T, Karaboga H, Dey P, et al.
PLoS One
. 2014 Sep;
9(9):e106289.
PMID: 25184494
Pancreatic ductal adenocarcinoma (PDAC) is difficult to detect early and is often resistant to standard chemotherapeutic options, contributing to extremely poor disease outcomes. Members of the nuclear receptor superfamily carry...
10.
You Y, Li X, Zheng J, Wu Y, He Y, Du W, et al.
Leuk Res
. 2013 Oct;
37(12):1636-41.
PMID: 24119536
To clarify the role of nucleostemin (NS) in AML, its transcription levels in bone marrow (BM) samples obtained from 128 newly diagnosed AML patients were analyzed. We determined that the...